Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 4812

1.

Role of Reelin in cell positioning in the cerebellum and the cerebellum-like structure in zebrafish.

Nimura T, Itoh T, Hagio H, Hayashi T, Di Donato V, Takeuchi M, Itoh T, Inoguchi F, Sato Y, Yamamoto N, Katsuyama Y, Del Bene F, Shimizu T, Hibi M.

Dev Biol. 2019 Jul 16. pii: S0012-1606(19)30049-1. doi: 10.1016/j.ydbio.2019.07.010. [Epub ahead of print]

PMID:
31323192
2.

Relationship between muscle-strengthening activities recommended by physical activity guidelines and knee extensor strength in the elderly.

Yamamoto N, Kawakami T, Hongu N, Asai H, Hagi Y.

J Phys Ther Sci. 2019 Jun;31(6):482-487. doi: 10.1589/jpts.31.482. Epub 2019 Jun 1.

PMID:
31320783
3.

First prospective feasibility study of Carbon-Ion radiotherapy using compact superconducting rotating gantry.

Bhattacharyya T, Koto M, Ikawa H, Hayashi K, Hagiwara Y, Makishima H, Kasuya G, Yamamoto N, Kamada T, Tsuji H.

Br J Radiol. 2019 Jul 18:20190370. doi: 10.1259/bjr.20190370. [Epub ahead of print]

PMID:
31317764
4.

Surgical treatment of chondroblastoma using extended intralesional curettage with phenol as a local adjuvant.

Zekry KM, Yamamoto N, Hayashi K, Takeuchi A, Araki Y, Alkhooly AZA, Abd-Elfattah AS, Fouly EH, Elsaid ANS, Tsuchiya H.

J Orthop Surg (Hong Kong). 2019 Sep-Dec;27(3):2309499019861031. doi: 10.1177/2309499019861031.

PMID:
31315494
5.

Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.

Abe K, Yamamoto N, Hayashi K, Takeuchi A, Tsuchiya H.

BMC Cancer. 2019 Jul 15;19(1):689. doi: 10.1186/s12885-019-5891-y.

6.

C-arm cone-beam computed tomography-guided minimally invasive open excision of an osteoid osteoma undetectable on fluoroscopy: A case report.

Higuchi T, Yamamoto N, Hayashi K, Takeuchi A, Abe K, Taniguchi Y, Araki Y, Tsuchiya H.

Int J Surg Case Rep. 2019 Jul 8;61:14-19. doi: 10.1016/j.ijscr.2019.06.062. [Epub ahead of print]

7.

The Combination of Olaratumab with Doxorubicin and Cisplatinum Regresses a Chemotherapy-Resistant Osteosarcoma in a Patient-Derived Orthotopic Xenograft Mouse Model.

Higuchi T, Sugisawa N, Miyake K, Oshiro H, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Bouvet M, Singh SR, Tsuchiya H, Hoffman RM.

Transl Oncol. 2019 Jul 9;12(9):1257-1263. doi: 10.1016/j.tranon.2019.06.002. [Epub ahead of print]

8.

An easy and reliable method to close Petersen's defect using barbed suture to prevent internal hernia from developing after gastrectomy with Roux-en-Y reconstruction.

Hara K, Hayashi T, Nakazono M, Nagasawa S, Shimoda Y, Kumazu Y, Yamada T, Yamamoto N, Shiozawa M, Morinaga S, Yoshikawa T, Rino Y, Masuda M, Ogata T, Oshima T.

Asian J Endosc Surg. 2019 Jul 12. doi: 10.1111/ases.12732. [Epub ahead of print]

PMID:
31297969
9.

Rapid screening and early precautions for carbapenem-resistant Acinetobacter baumannii carriers decreased nosocomial transmission in hospital settings: a quasi-experimental study.

Yamamoto N, Hamaguchi S, Akeda Y, Santanirand P, Chaihongsa N, Sirichot S, Chiaranaicharoen S, Hagiya H, Yamamoto K, Kerdsin A, Okada K, Yoshida H, Hamada S, Oishi K, Malathum K, Tomono K.

Antimicrob Resist Infect Control. 2019 Jun 27;8:110. doi: 10.1186/s13756-019-0564-9. eCollection 2019.

10.

Vitamin B12 deficiency anemia in an exclusively breastfed infant born to an ileum-resected mother.

Tamura A, Nino N, Yamamoto N, Naito A, Matsubara K, Nakatani N, Ichikawa T, Nakamura S, Saito A, Kozaki A, Kishimoto K, Ishida T, Shigematsu Y, Hasegawa D, Kosaka Y.

Pediatr Neonatol. 2019 Jun 11. pii: S1875-9572(19)30018-X. doi: 10.1016/j.pedneo.2019.06.002. [Epub ahead of print] No abstract available.

11.

Combination of Vaccine Strain Measles Virus and Nimotuzumab in the Treatment of Laryngeal Cancer.

Toan NL, Hang NT, Luu NK, VAN Mao C, VAN Ba N, Xuan NT, Cam TD, Yamamoto N, VAN Tong H, Son HA.

Anticancer Res. 2019 Jul;39(7):3727-3737. doi: 10.21873/anticanres.13521.

PMID:
31262899
12.

A minimum of 100 tumor cells in a single biopsy sample is required to assess programmed cell death ligand 1 expression in predicting patient response to nivolumab treatment in non-squamous non-small cell lung carcinoma.

Naito T, Udagawa H, Sato J, Horinouchi H, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Zenke Y, Kirita K, Matsumoto S, Yoh K, Niho S, Motoi N, Ohe Y, Ishii G, Goto K.

J Thorac Oncol. 2019 Jun 28. pii: S1556-0864(19)30501-5. doi: 10.1016/j.jtho.2019.06.019. [Epub ahead of print]

PMID:
31260834
13.

In Which Arm Position Is a Hill-Sachs Lesion Created?

Kawakami J, Yamamoto N, Hatta T, Shinagawa K, Itoi E.

Am J Sports Med. 2019 Jun 27:363546519858418. doi: 10.1177/0363546519858418. [Epub ahead of print]

PMID:
31246498
14.

A patient with Nivolumab-related Fulminant Type 1 Diabetes Mellitus whose Serum C-peptide Level Was Preserved at the Initial Detection of Hyperglycemia.

Yamamoto N, Tsurutani Y, Katsuragawa S, Kubo H, Sunouchi T, Hirose R, Hoshino Y, Ichikawa M, Takiguchi T, Yukawa H, Arioka H, Saitou J, Nishikawa T.

Intern Med. 2019 Jun 27. doi: 10.2169/internalmedicine.2780-19. [Epub ahead of print]

15.

Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).

Kimura T, Kawaguchi T, Chiba Y, Yoshioka H, Watanabe K, Kijima T, Kogure Y, Oguri T, Yoshimura N, Niwa T, Kasai T, Hayashi H, Ono A, Asai K, Tanaka H, Yano S, Yamamoto N, Nakanishi Y, Nakagawa K.

Jpn J Clin Oncol. 2019 Jun 26. pii: hyz088. doi: 10.1093/jjco/hyz088. [Epub ahead of print]

PMID:
31242302
16.

Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib.

Tamura K, Nukiwa T, Gemma A, Yamamoto N, Mizushima M, Ochai K, Ikeda R, Azuma H, Nakanishi Y.

Int J Clin Oncol. 2019 Jun 25. doi: 10.1007/s10147-019-01488-w. [Epub ahead of print]

PMID:
31240497
17.

Aligned carbon nanotube morphogenesis predicts physical properties of their polymer nanocomposites.

Natarajan B, Stein IY, Lachman N, Yamamoto N, Jacobs DS, Sharma R, Liddle JA, Wardle BL.

Nanoscale. 2019 Jun 24. doi: 10.1039/c9nr03317c. [Epub ahead of print]

PMID:
31233061
18.

Pazopanib maintenance therapy after tandem high-dose chemotherapy for disseminated Ewing sarcoma.

Tamura A, Yamamoto N, Nino N, Ichikawa T, Nakatani N, Nakamura S, Saito A, Kozaki A, Kishimoto K, Ishida T, Yoshida M, Akasaka Y, Hasegawa D, Kosaka Y.

Int Cancer Conf J. 2019 Feb 14;8(3):95-100. doi: 10.1007/s13691-019-00362-w. eCollection 2019 Jul.

PMID:
31218182
19.

Home safety practices to prevent child injury and its association with family and children's daily routines in Japan: A cross-sectional study.

Honda C, Naruse T, Tsuchiya-Ito R, Yamamoto N, Nagata S.

Jpn J Nurs Sci. 2019 Jun 19. doi: 10.1111/jjns.12274. [Epub ahead of print]

PMID:
31216107
20.

Dynamics of Minimal Residual Disease in Neuroblastoma Patients.

Uemura S, Ishida T, Thwin KKM, Yamamoto N, Tamura A, Kishimoto K, Hasegawa D, Kosaka Y, Nino N, Lin KS, Takafuji S, Mori T, Iijima K, Nishimura N.

Front Oncol. 2019 Jun 4;9:455. doi: 10.3389/fonc.2019.00455. eCollection 2019. Review.

21.

Development of a Noninvasive Skin Evaluation Method for Lower Limb Lymphedema.

Sano M, Hirakawa S, Yamanaka Y, Naruse E, Inuzuka K, Saito T, Katahashi K, Yata T, Kayama T, Tsuyuki H, Yamamoto N, Takeuchi H, Unno N.

Lymphat Res Biol. 2019 Jun 18. doi: 10.1089/lrb.2018.0089. [Epub ahead of print]

PMID:
31211932
22.

Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer.

Akiyoshi T, Tanaka N, Kiyotani K, Gotoh O, Yamamoto N, Oba K, Fukunaga Y, Ueno M, Mori S.

Br J Surg. 2019 Jun 13. doi: 10.1002/bjs.11179. [Epub ahead of print]

PMID:
31197828
23.

Feasibility of genomic profiling with next-generation sequencing using specimens obtained by image-guided percutaneous needle biopsy.

Sone M, Arai Y, Sugawara S, Kubo T, Itou C, Hasegawa T, Umakoshi N, Yamamoto N, Sunami K, Hiraoka N, Kubo T.

Ups J Med Sci. 2019 Apr;124(2):119-124. doi: 10.1080/03009734.2019.1607635.

24.

Difference in central nerve system metastasis during gefitinib or erlotinib therapy in patients with EGFR-mutated non-small cell lung cancer: a retrospective study.

Yoshida K, Kanda S, Shiraishi H, Goto K, Itahashi K, Goto Y, Horinouchi H, Fujiwara Y, Nokihara H, Yamamoto N, Ohe Y.

J Thorac Dis. 2019 Apr;11(4):1347-1354. doi: 10.21037/jtd.2019.03.61.

25.

A case of mediastinitis with an exposed artificial blood vessel that was associated with right ventricular wall damage during treatment.

Yoshida R, Yamamoto N, Nishijima A, Maruyama E, Takikawa M, Yanagibayashi S.

Case Reports Plast Surg Hand Surg. 2019 May 10;6(1):55-59. doi: 10.1080/23320885.2019.1611435. eCollection 2019.

26.

NUPR1 acts as a pro-survival factor in human bone marrow-derived mesenchymal stem cells and is induced by the hypoxia mimetic reagent deferoxamine.

Matsunaga K, Fujisawa K, Takami T, Burganova G, Sasai N, Matsumoto T, Yamamoto N, Sakaida I.

J Clin Biochem Nutr. 2019 May;64(3):209-216. doi: 10.3164/jcbn.18-112. Epub 2019 Mar 23.

27.

Structural Insights into the Inhibition of Amyloid Fibril Formation by Fibrinogen via Interaction with Prefibrillar Intermediates.

Yamamoto N, Akai T, Inoue R, Sugiyama M, Tamura A, Chatani E.

Biochemistry. 2019 Jun 18;58(24):2769-2781. doi: 10.1021/acs.biochem.9b00439. Epub 2019 Jun 5.

PMID:
31135143
28.

Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse model.

Igarashi K, Kawaguchi K, Kiyuna T, Miyake K, Miyake M, Nelson SD, Russell TA, Dry SM, Li Y, Yamamoto N, Hayashi K, Kimura H, Miwa S, Higuchi T, Singh SR, Tsuchiya H, Hoffman RM.

Tissue Cell. 2019 Jun;58:107-111. doi: 10.1016/j.tice.2019.04.010. Epub 2019 May 3.

PMID:
31133237
29.

Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours.

Ebata T, Shimizu T, Fujiwara Y, Tamura K, Kondo S, Iwasa S, Yonemori K, Shimomura A, Kitano S, Koyama T, Sato N, Nakai K, Inatani M, Yamamoto N.

Invest New Drugs. 2019 May 24. doi: 10.1007/s10637-019-00787-3. [Epub ahead of print]

PMID:
31124055
30.

Cytokine expression profiles in cervical mucus from patients with cervical cancer and its precursor lesions.

Otani S, Fujii T, Kukimoto I, Yamamoto N, Tsukamoto T, Ichikawa R, Nishio E, Iwata A.

Cytokine. 2019 Aug;120:210-219. doi: 10.1016/j.cyto.2019.05.011. Epub 2019 May 20.

31.

Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study.

Hagiya H, Kokado R, Ueda A, Okuno H, Morii D, Hamaguchi S, Yamamoto N, Yoshida H, Tomono K.

Intern Med. 2019 May 22. doi: 10.2169/internalmedicine.2603-18. [Epub ahead of print]

32.

Preparation of Induced Pluripotent Stem Cells Using Human Peripheral Blood Monocytes.

Isogai S, Yamamoto N, Hiramatsu N, Goto Y, Hayashi M, Kondo M, Imaizumi K.

Cell Reprogram. 2018 Dec;20(6):347-355. doi: 10.1089/cell.2018.0024.

33.

Peritoneal dissemination of ascending colon cancer demonstrating relapse-free survival for 40 months with panitumumab monotherapy: A case report.

Tokuhara K, Yamamoto N, Hishikawa H, Yoshioka K.

Int J Surg Case Rep. 2019;59:41-45. doi: 10.1016/j.ijscr.2019.05.001. Epub 2019 May 9.

34.

Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer.

Park K, Bennouna J, Boyer M, Hida T, Hirsh V, Kato T, Lu S, Mok T, Nakagawa K, O'Byrne K, Paz-Ares L, Schuler M, Sibilot DM, Tan EH, Tanaka H, Wu YL, Yang JC, Zhang L, Zhou C, Märten A, Tang W, Yamamoto N.

Lung Cancer. 2019 Jun;132:126-131. doi: 10.1016/j.lungcan.2019.04.014. Epub 2019 Apr 10.

35.

Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab.

Oyanagi J, Koh Y, Sato K, Mori K, Teraoka S, Akamatsu H, Kanai K, Hayata A, Tokudome N, Akamatsu K, Nakanishi M, Ueda H, Yamamoto N.

Lung Cancer. 2019 Jun;132:107-113. doi: 10.1016/j.lungcan.2019.03.020. Epub 2019 Mar 22.

PMID:
31097082
36.

Impact of CYP3A5, POR, and CYP2C19 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation.

Suetsugu K, Mori Y, Yamamoto N, Shigematsu T, Miyamoto T, Egashira N, Akashi K, Masuda S.

Int J Mol Sci. 2019 May 15;20(10). pii: E2413. doi: 10.3390/ijms20102413.

37.

A "Back Light System" for Identification of Sites for Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Solid Pancreatic Masses: A Prospective, Randomized Study with a Crossover Design.

Harada R, Kato H, Fushimi S, Inoue H, Uchida D, Akimoto Y, Tomoda T, Matsumoto K, Noma Y, Yamamoto N, Horiguchi S, Tsutsumi K, Okada H.

Clin Endosc. 2019 May 16. doi: 10.5946/ce.2019.004. [Epub ahead of print]

38.

Biomechanical Loading Comparison between Titanium and Unsintered Hydroxyapatite/Poly-L-Lactide Plate System for Fixation of Mandibular Subcondylar Fractures.

Sukegawa S, Kanno T, Yamamoto N, Nakano K, Takabatake K, Kawai H, Nagatsuka H, Furuki Y.

Materials (Basel). 2019 May 13;12(9). pii: E1557. doi: 10.3390/ma12091557.

39.

Phase I/II Study of Osimertinib With Bevacizumab in EGFR-mutated, T790M-positive Patients With Progressed EGFR-TKIs: West Japan Oncology Group 8715L (WJOG8715L).

Akamatsu H, Teraoka S, Morita S, Katakami N, Tachihara M, Daga H, Yamamoto N, Nakagawa K.

Clin Lung Cancer. 2019 Jul;20(4):e492-e494. doi: 10.1016/j.cllc.2019.03.002. Epub 2019 Mar 19.

40.

Tracing of Afferent Connections in the Zebrafish Cerebellum Using Recombinant Rabies Virus.

Dohaku R, Yamaguchi M, Yamamoto N, Shimizu T, Osakada F, Hibi M.

Front Neural Circuits. 2019 Apr 24;13:30. doi: 10.3389/fncir.2019.00030. eCollection 2019.

41.

Risk stratification for lymph node metastasis using Epstein-Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study.

Osumi H, Kawachi H, Murai K, Kusafuka K, Inoue S, Kitamura M, Yoshio T, Kakusima N, Ishihara R, Ono H, Yamamoto N, Sugino T, Nakatsuka S, Ida S, Nunobe S, Bando E, Omori T, Takeuchi K, Fujisaki J.

Gastric Cancer. 2019 May 6. doi: 10.1007/s10120-019-00963-7. [Epub ahead of print]

PMID:
31062195
42.

Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials.

Koyama T, Kondo S, Shimizu T, Fujiwara Y, Morizane C, Sakamoto Y, Okusaka T, Yamamoto N.

Front Oncol. 2019 Apr 18;9:301. doi: 10.3389/fonc.2019.00301. eCollection 2019.

43.

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.

Akamatsu H, Ninomiya K, Kenmotsu H, Morise M, Daga H, Goto Y, Kozuki T, Miura S, Sasaki T, Tamiya A, Teraoka S, Tsubata Y, Yoshioka H, Hattori Y, Imamura CK, Katsuya Y, Matsui R, Minegishi Y, Mizugaki H, Nosaki K, Okuma Y, Sakamoto S, Sone T, Tanaka K, Umemura S, Yamanaka T, Amano S, Hasegawa K, Morita S, Nakajima K, Maemondo M, Seto T, Yamamoto N.

Int J Clin Oncol. 2019 Jul;24(7):731-770. doi: 10.1007/s10147-019-01431-z. Epub 2019 May 2.

44.

A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1-4, as a single dose and multiple doses in patients with solid malignancies.

Yamamoto N, Ryoo BY, Keam B, Kudo M, Lin CC, Kunieda F, Ball HA, Moran D, Komatsu K, Takeda K, Fukuda M, Furuse J, Morita S, Doi T.

Invest New Drugs. 2019 Apr 30. doi: 10.1007/s10637-019-00780-w. [Epub ahead of print]

PMID:
31041575
45.

Tumor expression and usefulness as a biomarker of programmed death ligand 1 in advanced non-small cell lung cancer patients with preexisting interstitial lung disease.

Shibaki R, Murakami S, Matsumoto Y, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Motoi N, Kusumoto M, Yamamoto N, Ohe Y.

Med Oncol. 2019 Apr 27;36(6):49. doi: 10.1007/s12032-019-1274-0.

PMID:
31030326
46.

Corrigendum to "Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer" [Lung Cancer 121 (July) (2018) Pages 37-40].

Nishio M, Nakagawa K, Mitsudomi T, Yamamoto N, Tanaka T, Kuriki H, Zeaiter A, Tamura T.

Lung Cancer. 2019 Jun;132:160. doi: 10.1016/j.lungcan.2019.04.012. Epub 2019 Apr 24. No abstract available.

47.

Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study).

Akamatsu H, Koh Y, Okamoto I, Fujimoto D, Bessho A, Azuma K, Morita S, Yamamoto N, Nakagawa K.

Lung Cancer. 2019 May;131:128-133. doi: 10.1016/j.lungcan.2019.03.021. Epub 2019 Mar 22.

48.

Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains.

Nakano T, Okano H, Takahashi M, Nagashima S, Shiraki K, Oya Y, Inoue H, Ohmori S, Tsukimoto M, Ishida S, Fujimoto S, Kobayashi M, Yamawaki M, Kumagai M, Ninomiya J, Maegawa T, Kojima Y, Araki J, Hamaoka S, Horiike S, Yoshimura H, Takeuchi K, Itoh K, Akachi S, Uraki S, Yamamoto N, Ogura S, Sugimoto K, Yoshikawa K, Hasegawa H, Iwasa M, Takei Y, Okamoto H.

Hepatol Res. 2019 Apr 26. doi: 10.1111/hepr.13357. [Epub ahead of print]

PMID:
31026368
49.

Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy.

Yamamoto N, Watanabe T, Yamada K, Nakai T, Suzumura T, Sakagami K, Yoshimoto N, Sato K, Tanaka H, Mitsuoka S, Asai K, Kimura T, Kanazawa H, Hirata K, Kawaguchi T.

J Thorac Dis. 2019 Mar;11(3):936-943. doi: 10.21037/jtd.2019.01.88.

50.

Dietary Calcium Intake and Hypertension: Importance of Serum Concentrations of 25-Hydroxyvitamin D.

Nakamura H, Tsujiguchi H, Hara A, Kambayashi Y, Miyagi S, Thu Nguyen TT, Suzuki K, Tao Y, Sakamoto Y, Shimizu Y, Yamamoto N, Nakamura H.

Nutrients. 2019 Apr 23;11(4). pii: E911. doi: 10.3390/nu11040911.

Supplemental Content

Loading ...
Support Center